Market closed

Seres Therapeutics/$MCRB

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Seres Therapeutics

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

Ticker

$MCRB
Trading on

Industry

Biotechnology

Employees

103

MCRB Metrics

BasicAdvanced
$88M
575.90
$0.02
2.53
-
$88M
2.53
$10.55
$7.18
0.938
0.797
601.901
664.829
-30.43%
809.55%
575.901
6.33
6.33
-0.526
-100.10%
-89.31%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $MCRB

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for Seres Therapeutics stock?

Seres Therapeutics (MCRB) has a market cap of $88M as of April 27, 2025.

What is the P/E ratio for Seres Therapeutics stock?

The price to earnings (P/E) ratio for Seres Therapeutics (MCRB) stock is 575.9 as of April 27, 2025.

Does Seres Therapeutics stock pay dividends?

No, Seres Therapeutics (MCRB) stock does not pay dividends to its shareholders as of April 27, 2025.

When is the next Seres Therapeutics dividend payment date?

Seres Therapeutics (MCRB) stock does not pay dividends to its shareholders.

What is the beta indicator for Seres Therapeutics?

Seres Therapeutics (MCRB) has a beta rating of 2.53. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.